Supernus Announces First Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- L3Harris CEO steps down amid conduct review, shares drop
- Oil settles up over $2 as Iran war stalemate stokes supply concerns
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
Supernus Pharma (SUPN) Misses Q1 EPS by 13c
May 7, 2019 5:13 PM EDTSupernus Pharma (NASDAQ: SUPN) reported Q1 EPS of $0.34, $0.13 worse than the analyst estimate of $0.47. Revenue for the quarter came in at $85.5 million versus the consensus estimate of $103.87 million.
Financial guidance reaffirmed
For earnings history and earnings-related data on Supernus Pharma (SUPN) click here.
... More